David Efraim Rosen, 10% Owner at TherapeuticsMD, Inc. (TXMD), bought 40,226 shares at $5.66 ($228K) on 2022-12-07, disclosed to the SEC on 2022-12-09.
Open-market purchase of $228k TXMD by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.66 | 20,113 | $114K | 50.0% |
| 2 | $5.66 | 20,113 | $114K | 50.0% |
| Total | $5.66 avg | 40,226 | $228K | 100% |
| Filing → |
| TXMD | BUY | 2022-08-01 | $2.7M | — | Filing → |
| TXMD | BUY | 2022-07-19 | $935K | — | Filing → |
| RDUS | BUY | 2021-12-15 | $6.4M | — | Filing → |